standardisation and security of nuclear medicine services · alternative radiopharmaceuticals...

36
The University of Nottingham Standardisation and Security of Nuclear Medicine Services Alan Perkins University of Nottingham The analysts’ dilemma. RSC 30 June 2011

Upload: others

Post on 06-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Standardisation and Security of Nuclear Medicine Services

Alan Perkins

University of Nottingham

The analysts’ dilemma. RSC 30 June 2011

Page 2: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am Standard chamber Setting standards Basic Safety Standards

Page 3: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Warning!

This presentation may require revision to meet the required standards.

Page 4: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Standardisation Dictionary definitions: •cause (something) to conform to a standard. •determine the properties of (something) by comparison with a standard. •the process of establishing a standard which could be a technical standard, standard test method, standard definition, standard procedure (or practice)….

Page 5: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

The National Institute for Health and Clinical Excellence (NICE) provides guidance, sets quality standards and manages a national database to improve people's health and prevent and treat ill health. Technology appraisals Recommendations on the use of new and existing medicines and treatments within the NHS, such as: •Medicines •medical devices (for example, hearing aids or inhalers) •diagnostic techniques (tests used to identify diseases) •surgical procedures (such as repairing hernias) •health promotion activities (for example, ways of helping people with diabetes manage their condition).

Page 6: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Standards in Nuclear Medicine

Page 7: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

References

1. International basic safety standards for protection against ionizing radiation and for the safety of radiation sources. Safety series 117 IAEA Vienna 1996.

2. Applying radiation safety standards in nuclear medicine. Safety reports series 40 IAEA Vienna 2005.

3. Nuclear Medicine Resources Manual. IAEA Vienna 2006. 4. ICRP Publication 94: Release of Patients after Therapy with Unsealed

Radionuclides. International Commission on Radiological Protection ISBN 0080445608 2005

5. Medical and dental guidance notes. IPEM York 2002

Page 8: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Global Perspective of Safety Standards

• Different perception of value of nuclear medicine

• Difference in priorities between different countries

• Complex relationships between practitioners,

researchers, industry and regulatory authorities

• Variable safety standards

• Implementation through peer review and audit

• Vast discrepancy in resources between different

countries

Page 9: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am Service Guidelines

Guidelines in Nuclear Medicine have been, and continue to be, developed by a number of organisations throughout the world. National regulations on the administration of radioactive substances and differences in clinical service delivery mean that guidelines do not readily apply across regional and national boundaries. In Europe, the European Association of Nuclear Medicine (EANM) is coordinating the development of guidelines, but recognises the need for national guidelines.

Page 10: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Page 11: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Page 12: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Audit and Standards Quality of Service Health and Safety

Standards relate to Legal requirements Regulatory obligations Notes for guidance Peer reviewed publications Accepted good clinical practice (GCP)

Page 13: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Example Radiopharmaceuticals for GI transit

Beef stew 99mTc Chicken liver 99mTc Dietry fibre 111In, 131I Egg sandwich 99mTc Filter paper in corn flakes (Technicrispies) 99mTc Mushrooms 99mTc Oatmeal 99mTc Pancake 99mTc,111In Porridge 99mTc,51Cr Rice 99mTc Scrambled egg on toast 99mTc

Page 14: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

SNM guideline Wide range of test meals used yet rarely validated 118ml (4oz) liquid egg whites 18 – 37MBq Tc-99m Su colloid Cook eggs in microwave oven to consistency of an omelette. 2 slices of toasted white bread 30g jam or jelly 120ml water May be eaten as a sandwich!

Page 15: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Page 16: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Security

• Safety.

• Continuation of service through secure supplies.

Page 17: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Post 9/11….. In the UK the police and Environment Agency Inspectors have been visiting departments to assess security. Previously dealing with accidental spill or loss but now…….

Page 18: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

WARNING ! RADIO INACTIVE

New Scientist 13 September 2008 British Medical Journal 2008;337:a1577

Page 19: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Medical Molybdenum Production

Reactor Tc-99m

Generator Manufacturing

Uranium-235 Mo-99 Tc-99m

Nuclear Pharmacy

Tc-99m and Companion Drug

Bulk Mo-99 Processing

Patient

Decay of Isotopes (“Half Life”)

• Mo-99: 66 hours

• Tc-99m: 6 hours

About 3-4 days

Page 20: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Molybdenum Deficiency

• Molybdenum deficiency is very rare recessive disorder that occurs when the body is lacking or cannot break down molybdenum.

• Like many other minerals, molybdenum is necessary for the the metabolisation of fats, carbohydrates, copper and nitrogen.

• It is normally obtained through a diet of beans, dark green leafy vegetables, rice and cereals.

• Those with the greatest risk of developing it are patients being fed intravenously.

Page 21: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

5 reactors produce over 90% world supply

Page 22: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Aging Fleet of Major Production Reactors

Location Name Age

Canada, Chalk River NRU 51

Belgium, Mol BR2 47

Netherlands, Petten HFR 47

South Africa, Pelindaba SAFARI-1 43

France, Saclay OSIRIS 42

Page 23: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Medical Isotopes – Global Supply Chain Structure

OSIRIS

MDS Nordion AECL

Lantheus (BMS)

Covidien

Covidien US

IRE IBA

NTP NTP

NRU

PETTEN

BR-2

Target Irradiation

Mo-99 Extraction

Mo-99 Purification

Tc-99m Generator Manufacturing &

Distribution

SAFARI AEC Amersham

Nuclear Medicine Market

Canada & US

Canada, US & Europe

Europe

Europe and ROW

Canada

Netherlands

Belgium

France

South Africa

Reactors Facilities

Covidien EU

Nihon

Daichi Japan

Czech LWR-15 REZ

MARIA Poland

Czech

Poland

Page 24: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

National Society Role

Communication Establish accurate communication with departments Ensure flow of information for service planning Society website www.bnms.org RSS feed

Engage with clinical departments Working groups Establish best practice Share solutions to short term shortages Include relevant information in surveys Education of users

Page 25: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Securing the supply Increased co-operation

Producers

Manufacturers

International Agencies e.g. OECD

Professional Societies

Hospital radiopharmacies

Service departments

Page 26: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Industry: AIPES established 1987

CYCLOPHARMALABORATOIRES

Page 27: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

National and International Collaboration

• COMMUNICATE WITH ALL STAKEHOLDERS IN CASE OF SHORTAGE

• EVALUATE AVAILABLE PRODUCTION AND IDENTIFY ALTERNATIVE SOURCES

• PROPOSE ALTERNATIVE ISOTOPES and DIAGNOSTIC PROCEDURES WHEN AVAILABLE

• PROVIDE ACCESS TO INFORMATION AND EXPERTISE TO THE MEDIA

• WORK WITH INDUSTRY AND AUTHORITIES FOR A LONG TERM SOLUTION

27

Page 28: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

OCTOBER 2010

F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M T

u W Th F Sa Su

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

Week 40 Week 41 Week 42 Week 43 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez

NOVEMBER 2010

M Tu W Th F Sa Su M Tu W Th F Sa Su M T

u W Th F Sa Su M Tu W Th F Sa Su M Tu

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30 -

Week 44 Week 45 Week 46 Week 47 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez

December 2010

W Th F Sa Su M Tu W Th F Sa Su M Tu W Th F Sa Su M T

u W Th F Sa Su M Tu W Th F

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

Week 48 Week 49 Week 50 Week 51 Week 52 HFR Petten OSI Saclay BR2 Mol Safari Pelindaba NRU Chalk River MARIA Otwock-Swierk OPAL Menai LVR15 Rez

Page 29: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Key Challenges • Isotope Production

– Limited number of aging reactors – Limited new sources of supply – New sources require significant time and investment to

deploy • Supply Chain

– Logistics of delivery of a decaying product – Complex supply chain with multiple public and private

sector participants • Regulation

– Radioactivity + Pharmacueticals (GMP) – Nuclear security – HEU/LEU – Transport

Page 30: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Maintaining Clinical Services

• Reappraisal of what we do

• Improved equipment performance

• Better use of less activity

• Lower radiation doses

Page 31: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Establishing Clinical Priority

1. Paediatric studies e.g. oncology and renography 2. Sentinel lymph node localisation 3. Studies in which other imaging modalities are

specifically contraindicated. e.g. patients in renal failure where i.v. contrast

may not be given for CT or MR.

Page 32: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Maintaining Clinical Services Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine” F-18-NaF Reducing waste Avoid wasteful practice e.g. Tc-99m aerosol production Alternative diagnostic modalities CT MRI

Page 33: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Transportation

Page 34: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

The silver lining

• The crisis has raised the profile of Nuclear Medicine

• Reappraisal of clinical services.

• Better use of materials and alternative procedures.

• Increased the importance of equipment and software developments.

Page 35: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

Reactor production technologies 1. Conventional U-235 fission: Neutron + U-235 --> Mo-99 + neutrons + other fission products 2. Neutron activation of Mo-98: Neutron + Mo-98 --> Mo-99 Accelerator production technologies 1. Linear accelerator photo-fission of U-238 Photon + U-238 --> Mo-99 + neutrons + other fission products 2. Mo-100 transmutation Photon + Mo-100 --> Mo-99 + neutron 3. Direct cyclotron production of Tc-99m: Proton + Mo-100 --> Tc-99m + 2 neutrons

Page 36: Standardisation and Security of Nuclear Medicine Services · Alternative radiopharmaceuticals Tl-201 I-123 “ An emerging workhorse in nuclear medicine ” F-18-NaF Reducing waste

The

Un

iver

sity

of

No

ttin

gh

am

From the early early mornin’ to the early early night,

When I caught miss Molly rockin' at the house of blue lights,

Good Golly Miss Moly